I would think that the companyhas to do a CR before the...

I would think that the companyhas to do a CR before the commencement (or in the early stages) of the Phase 2trials.

Would it be preferable for thecompany to seek a NASDAQ listing and raise the cash via the IPO?

Alternatively, a buy in by a downstreamuser?

But it doesn’t appear that theCR will occur in Australia.

Any views on this?

As a matter of interest, youmay recall that ResMed started out as an Australian company with a CPAPinvention. It now has some 8,000 employees and operates in approx. 140 countries. It hasmanufacturing facilities in Australia, Singapore, France, and the US.ResMed is listed on both the ASX and the NYSE. There’s no reason why IBX can’tachieve a similar global outcome.

DISCLAIMER: I am not qualifiedin any of this and the above is my idle speculation only and not financialadvice of any kind. So please do your own research.

Regards, Stretguy